Clinical Trial Update: A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for durvalumab in combination with doxorubicin in advanced soft tissue sarcoma (Phase 1/2) with undisclosed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Durvalumab (durvalumab)

Snippet

Sponsor: Yonsei University | Conditions: Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN